大麻二酚油对输尿管镜术后泌尿系结石疼痛的影响:一项随机双盲安慰剂对照试验
这项前瞻性随机双盲安慰剂对照试验在三级医疗中心纳入90例因泌尿系结石行输尿管镜并留置支架的患者,按1:1随机分配至安慰剂组或术后每日20 mg大麻二酚油(Epidiolex)组,持续3天。结果显示两组术后疼痛评分、阿片类药物使用及输尿管支架症状问卷各项评分均无差异,大麻二酚油安全但无效。
要点
- 大麻二酚油20 mg每日一次连用3天,与安慰剂相比未降低输尿管镜术后疼痛评分。
- 两组阿片类药物使用量及输尿管支架症状问卷(体力活动、睡眠、排尿、日常生活)评分均无差异。
- 大麻二酚油在该人群中安全,但未能减少术后支架不适或阿片类药物使用。
核心结论
- 这项随机双盲安慰剂对照试验表明,与安慰剂相比,大麻二酚油在减轻输尿管镜术后支架不适或阿片类药物使用方面安全但无效。
研究设计与样本
- 前瞻性、随机、双盲、安慰剂对照试验,在三级医疗中心纳入90例因泌尿系结石行输尿管镜并留置支架的患者,按1:1随机分配至安慰剂组或术后每日20 mg大麻二酚油组,持续3天。
主要发现
- 安慰剂组与大麻二酚油组在术前和围手术期特征方面无差异。
- 两组术后疼痛评分无差异。
- 两组术后阿片类药物使用无差异。
- 两组在体力活动、睡眠、排尿和日常生活方面的输尿管支架不适程度均无差异。
临床怎么用
- 作者指出,尽管有多种镇痛药物可用,支架症状仍是多数患者的不满来源,提示后续工作需聚焦于新型干预和疼痛控制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Post-ureteroscopy stent placement carries significant morbidity which can interfere with daily life. This discomfort unfortunately leads to high utilization of opioid pain medications, which have a known risk of addiction. Cannabidiol oil represents an alternative analgesic that has proven anti-inflammatory and antinociceptive effects. The purpose was to evaluate the effect of a Food and Drug Administration-approved cannabidiol oil (Epidiolex) on pain control and opioid usage in the post-ureteroscopy setting. MATERIALS AND METHODS: This was a prospective, randomized, double-blind, placebo-controlled trial at a tertiary care center. Ninety patients undergoing ureteroscopy with stent placement for urinary stone disease were randomized 1:1 to placebo or 20 mg cannabidiol oil daily for 3 days postoperatively. Both groups were prescribed a rescue narcotic, tamsulosin, oxybutynin, and phenazopyridine. Daily pain scores, medication usage, and ureteral stent symptoms using the validated Ureteral Stent Symptom Questionnaire were recorded postoperatively. RESULTS: Both the placebo and cannabidiol oil groups were not different in pre- and perioperative characteristics. There was no difference in pain scores or opioid usage between groups postoperatively. The level of discomfort with ureteral stents was also not different between groups when comparing physical activity, sleep, urination, and activities of daily life. CONCLUSIONS: This randomized, blinded, placebo-controlled trial showed that cannabidiol oil is safe but ineffective when compared to placebo in reducing post-ureteroscopic stent discomfort or opioid usage. Despite the availability of numerous analgesic agents, stent symptoms continue to be a dissatisfier for most patients, suggesting additional work needs to focus on novel interventions and pain control.
引用
- Narang G, Moore J, Wymer K, et al. Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial. J Urol. 2023. PMID: 36891837. doi:10.1097/JU.0000000000003139
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。